It follows a once-weekly injection schedule with a gradual step-up approach, starting low and increasing every few weeks to help your body adjust
Weekly subcutaneous injections currently offer the most reliable pharmacokinetics, bioavailability, and efficacy, producing consistent weight-loss outcomes and strong cardiovascular benefits
Data from the surpass trial series revealed that tirzepatide reduces the risk of major adverse cardiovascular events and improves blood pressure, lipid profiles, and inflammatory markers (60, 61)
Each serving gives you 42 grams of protein and roughly 12 grams of fiber, addressing two of the biggest nutritional challenges on these medications: muscle preservation and constipation prevention
doi: 10.1016/S0140-6736(19)31150-X 15 GersteinH
But insurance companies want to keep costs down themselves, so many won't cover them for weight loss, or require patients to jump through frustrating hoops to get approval for coverage